M Temprosa
Overview
Explore the profile of M Temprosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
463
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwartz A, Pan Q, Aroda V, Crandall J, Kriska A, Piromalli C, et al.
Osteoporos Int
. 2021 Jun;
32(11):2279-2287.
PMID: 34086101
Introduction: Randomization to lifestyle intervention (ILS) or metformin in the Diabetes Prevention Program (DPP) resulted in weight loss and reduced progression to diabetes. Weight loss is associated with reduced bone...
2.
Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, et al.
J Clin Endocrinol Metab
. 2013 Aug;
98(10):3989-98.
PMID: 23979954
Context: Although intensive lifestyle change (ILS) and metformin reduce diabetes incidence in subjects with impaired glucose tolerance (IGT), their effects on lipoprotein subfractions have not been studied. Objective: The objective...
3.
Christophi C, Resnick H, Ratner R, Temprosa M, Fowler S, Knowler W, et al.
J Diabetes Complications
. 2012 Nov;
27(2):150-7.
PMID: 23140912
Aims: To examine the ability of fasting plasma glucose (FPG) and/or 2-h glucose to confirm diabetes and to determine the proportion of participants with HbA1c ≥6.5%. Methods: Diabetes confirmation rates...
4.
Orchard T, Temprosa M, Barrett-Connor E, Fowler S, Goldberg R, Mather K, et al.
Diabet Med
. 2012 Jul;
30(1):46-55.
PMID: 22812594
Aims: Whether long-term cardiovascular risk is reduced by the Diabetes Prevention Program interventions is unknown. The aim of this study was to determine the long-term differences in cardiovascular disease risk...
5.
Lemons J, Bauer C, Oh W, KORONES S, Papile L, Stoll B, et al.
Pediatrics
. 2001 Jan;
107(1):E1.
PMID: 11134465
Objectives: To determine the mortality and morbidity for infants weighing 401 to 1500 g (very low birth weight [VLBW]) at birth by gestational age, birth weight, and gender. Study Design:...
6.
Stoll B, Temprosa M, Tyson J, Papile L, Wright L, Bauer C, et al.
Pediatrics
. 1999 Nov;
104(5):e63.
PMID: 10545589
Background: Infection is a major complication of preterm infants, resulting in increased morbidity and mortality. We recently reported the results of a multicenter trial of dexamethasone initiated at 14 or...